Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05743491 · ClinicalTrials.gov registry record · NA

Yoga Versus Standard Care for Reducing Fatigue in Hispanic Cancer Survivors (YOCAS©®)

A NA study, sponsored by University of Rochester.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT05743491: Clinical Trial NA study, sponsored by University of Rochester.

NCT05743491 is a NA study that was terminated before completion, run by University of Rochester. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05743491, a NA study, was terminated before completion, sponsored by University of Rochester.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

This is a phase II 2-arm randomized controlled trial comparing yoga (Yoga for Cancer Survivors, YOCAS©®) to standard care in reducing cancer-related fatigue in Hispanic cancer survivors. Survivors randomized to Arm 1 will receive Standard Care and Arm 2 will receive standard care plus a four-week YOCAS©® intervention where Hispanic survivors attend yoga sessions together. Investigators will acquire preliminary data on cancer-related fatigue, as well as, secondary data on other common side effects.

Primary Outcome

The MFSI is a multidimensional 30-item fatigue scale developed specifically for documenting cancer-related fatigue. The total MFSI-SF score ranges from -24 to 96, with a higher score indicating a higher fatigue level.

Interventions

  • OTHER Standard Care
  • BEHAVIORAL YOCAS©®

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2023-04-12
Est. Completion 2023-08-16
Phase NA
University of Rochester

636 total trials

Why NCT05743491 stopped before completion

NCT05743491 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.

NCT05743491 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05743491 about?

NCT05743491 is a clinical study titled "Yoga Versus Standard Care for Reducing Fatigue in Hispanic Cancer Survivors (YOCAS©®)". This is a phase II 2-arm randomized controlled trial comparing yoga (Yoga for Cancer Survivors, YOCAS©®) to standard care in reducing cancer-related fatigue in Hispanic cancer survivors. Survivors randomized to Arm 1 will receive Standard Care and Arm 2 will receive standard care plus a four-week YO...

What is the current status of trial NCT05743491?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2023-04-12. Estimated completion is 2023-08-16.

What interventions are being tested in trial NCT05743491?

The interventions under investigation include: Standard Care (OTHER), YOCAS©® (BEHAVIORAL).

Who is sponsoring clinical trial NCT05743491?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05743491's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05743491, the US trial registry maintained by the National Library of Medicine. NCT05743491 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.